Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 Vaccine Safety in Children Aged 5–11 Years — United States, November 3–December 19, 2021
Anne M. Hause, James Baggs, Paige Marquez, et al.
MMWR Morbidity and Mortality Weekly Report (2021) Vol. 70, Iss. 5152, pp. 1755-1760
Open Access | Times Cited: 163

Showing 1-25 of 163 citing articles:

Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review
Jennifer Pillay, L. Gaudet, Aireen Wingert, et al.
BMJ (2022), pp. e069445-e069445
Open Access | Times Cited: 115
Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5–11 years in Italy: a retrospective analysis of January–April, 2022
Chiara Sacco, Martina Del Manso, Alberto Mateo‐Urdiales, et al.
The Lancet (2022) Vol. 400, Iss. 10346, pp. 97-103
Open Access | Times Cited: 110
A truncated pre-F protein mRNA vaccine elicits an enhanced immune response and protection against respiratory syncytial virus
Min Lin, Yifan Yin, Xiaomeng Zhao, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
The Importance of Vaccination in the Context of the COVID-19 Pandemic: A Brief Update Regarding the Use of Vaccines
Bruna Aparecida Souza Machado, Katharine Valéria Saraiva Hodel, Larissa Moraes dos Santos Fonseca, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 591-591
Open Access | Times Cited: 63
Association of Social Determinants of Health and Vaccinations With Child Mental Health During the COVID-19 Pandemic in the US
Yunyu Xiao, Paul Siu-Fai Yip, Jyotishman Pathak, et al.
JAMA Psychiatry (2022) Vol. 79, Iss. 6, pp. 610-610
Open Access | Times Cited: 49
SARS-CoV-2 infection in children and implications for vaccination
Jordan Nathanielsz, Zheng Quan Toh, Lien Anh Ha, et al.
Pediatric Research (2022) Vol. 93, Iss. 5, pp. 1177-1187
Open Access | Times Cited: 49
Safety of COVID-19 Vaccination in United States Children Ages 5 to 11 Years
Anne M. Hause, David K. Shay, Nicola P. Klein, et al.
PEDIATRICS (2022) Vol. 150, Iss. 2
Open Access | Times Cited: 48
Effectiveness of an inactivated SARS-CoV-2 vaccine in children and adolescents: a large-scale observational study
Alejandro Jara, Eduardo A. Undurraga, Juan Carlos Flores, et al.
The Lancet Regional Health - Americas (2023) Vol. 21, pp. 100487-100487
Open Access | Times Cited: 22
Safety of Ancestral Monovalent BNT162b2, mRNA-1273, and NVX-CoV2373 COVID-19 Vaccines in US Children Aged 6 Months to 17 Years
Mao Hu, Azadeh Shoaibi, Yuhui Feng, et al.
JAMA Network Open (2024) Vol. 7, Iss. 4, pp. e248192-e248192
Open Access | Times Cited: 7
COVID-19 Vaccine Provider Access and Vaccination Coverage Among Children Aged 5–11 Years — United States, November 2021–January 2022
Christine Kim, Randy Yee, Roma Bhatkoti, et al.
MMWR Morbidity and Mortality Weekly Report (2022) Vol. 71, Iss. 10, pp. 378-383
Open Access | Times Cited: 34
Immunogenicity, effectiveness, and safety of COVID-19 vaccines among children and adolescents aged 2–18 years: an updated systematic review and meta-analysis
Peng Gao, Liangyu Kang, Jue Liu, et al.
World Journal of Pediatrics (2023) Vol. 19, Iss. 11, pp. 1041-1054
Open Access | Times Cited: 21
Safety of the BNT162b2 COVID-19 Vaccine in Children Aged 5 to 17 Years
Mao Hu, Hui Lee Wong, Yuhui Feng, et al.
JAMA Pediatrics (2023) Vol. 177, Iss. 7, pp. 710-710
Open Access | Times Cited: 20
Overview of U.S. COVID-19 vaccine safety surveillance systems
Julianne Gee, Tom T. Shimabukuro, John R. Su, et al.
Vaccine (2024) Vol. 42, pp. 125748-125748
Open Access | Times Cited: 7
Unraveling Cardiovascular Risks and Benefits of COVID-19 Vaccines: A Systematic Review
Shakta Mani Satyam, Mohamed El‐Tanani, Laxminarayana Kurady Bairy, et al.
Cardiovascular Toxicology (2025)
Closed Access
Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5–11 Years — United States, May 17–July 31, 2022
Anne M. Hause, James Baggs, Paige Marquez, et al.
MMWR Morbidity and Mortality Weekly Report (2022) Vol. 71, Iss. 33, pp. 1047-1051
Open Access | Times Cited: 26
Audiological and vestibular symptoms following SARS-CoV-2 infection and COVID-19 vaccination in children aged 5–11 years
Mirko Aldè, Federica Di Berardino, Umberto Ambrosetti, et al.
American Journal of Otolaryngology (2022) Vol. 44, Iss. 1, pp. 103669-103669
Open Access | Times Cited: 25
The v-safe after vaccination health checker: Active vaccine safety monitoring during CDC’s COVID-19 pandemic response
Tanya R. Myers, Paige Marquez, Julianne Gee, et al.
Vaccine (2023) Vol. 41, Iss. 7, pp. 1310-1318
Open Access | Times Cited: 15
Anaphylaxis rates following mRNA COVID-19 vaccination in children and adolescents: Analysis of data reported to EudraVigilance
Helena C. Maltezou, Sophia Hatziantoniou, Kalliopi Theodoridou, et al.
Vaccine (2023) Vol. 41, Iss. 14, pp. 2382-2386
Open Access | Times Cited: 13
Assessing the role of children in the COVID-19 pandemic in Belgium using perturbation analysis
Leonardo Angeli, Constantino Caetano, Nicolas Franco, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
The unjustified and politicized battle against vaccination of children and adolescents in Brazil
Paulo Ricardo Martins‐Filho, Lorena Barberia
The Lancet Regional Health - Americas (2022) Vol. 8, pp. 100206-100206
Open Access | Times Cited: 21
Effectiveness and Safety of SARS-CoV-2 Vaccines among Children and Adolescents: A Systematic Review and Meta-Analysis
Peng Gao, Shan Cai, Qiao Liu, et al.
Vaccines (2022) Vol. 10, Iss. 3, pp. 421-421
Open Access | Times Cited: 20
Effect of information provision on parental intention toward COVID-19 vaccination for children: a nationwide survey experiment
Hyunju Lee, Jung‐Hyun Park, Shinkyeong Kim, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Breakthrough COVID-19 Infections in the US: Implications for Prolonging the Pandemic
Donald J. Alcendor, Patricia Matthews-Juarez, Duane T. Smoot, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 755-755
Open Access | Times Cited: 17
Factors that differentiate COVID-19 vaccine intentions among Indiana parents: Implications for targeted vaccine promotion
Katharine J. Head, Gregory D. Zimet, Constantin T. Yiannoutsos, et al.
Preventive Medicine (2022) Vol. 158, pp. 107023-107023
Open Access | Times Cited: 16
Behavioral Intention and Its Predictors toward COVID-19 Booster Vaccination among Chinese Parents: Applying Two Behavioral Theories
Meng Zhou, Li Liu, Shuyan Gu, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 12, pp. 7520-7520
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top